益肾活血化痰胶囊治疗颈动脉粥样硬化的临床观察  被引量:7

Clinical Observation on Treating Carotid Atherosclerosis with Yishenhuoxuehuatan Capsule

在线阅读下载全文

作  者:王英震[1] 李洁 

机构地区:[1]山东省济南市第三人民医院,250101 [2]青岛市海慈医疗集团,266033

出  处:《中国医疗前沿》2013年第11期24-25,共2页China Healthcare Innovation

摘  要:目的观察益肾活血化痰胶囊治疗颈动脉粥样硬化的临床疗效。方法将162例颈动脉粥样硬化患者随机分为两组各81例,对照组采用常规基础治疗,治疗组在对照组基础上加服益肾活血化瘀胶囊,疗程均为24周。分别观察两组颈动脉内-中膜厚度(IMT)、斑块面积、高敏C反应蛋白(hc-CRP)及血脂,包括血清胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL-C)、低密度脂蛋白(LDL-C)的变化、不良反应。结果两组治疗后颈动脉IMT、斑块面积、hs-CRP、TC、TG、LDL-C显著降低,HDL-C显著升高,治疗后治疗组颈动脉IMT、斑块面积、hs-CRP、TC、LDL-C显著低于对照组,治疗过程中未见明显不良反应。结论益肾活血化痰胶囊对颈动脉粥样硬化有较好的治疗作用,且安全性良好。Objective To observe the clinical effect of Yishenhuoxuehuatan Capsule in the treatment of carotid atherosclerosis.Method 162 cases of carotid atherosclerosis were randomly divided into two groups:control group and treatment group.In addition to routine therapy of the control group,the therapy group was given Yishenhuoxuehuatan Capsule.After 24 weeks,observed the adverse reactions and differences of carotid artery intima-media thickness(IMT),plaque area,high-sensitivity C-reactive protein(hc-CRP) and serum lipids,serum cholesterol(TC),triglyceride(TG),high density lipoprotein(HDL-C),low-density lipoprotein(LDL-C) in the two groups.Result After treatment,carotid IMT,plaque area,hs-CRP,TC,TG,LDL-C of the two groups were significant decreased,HDL-C increased.Carotid IMT,plaque area,hs-CRP,TC,LDL-C of the treatment group were significantly lower than the control group,and no adverse reaction was detected in the course of treatment.Conclusion Yishenhuoxuehuatan Capsule has a better therapeutic effect on carotid atherosclerosis with a fairly good safety.

关 键 词:益肾活血化痰胶囊 颈动脉粥样硬化 临床观察 

分 类 号:R543.4[医药卫生—心血管疾病]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象